evidence table

Nicotinamide Riboside Exercise Performance Randomized Trial Evidence Table

Name: Nicotinamide Riboside Exercise Performance Randomized Trial Evidence Table
Creator: Migaku
License: https://creativecommons.org/licenses/by/4.0/

Structured evidence table for Nicotinamide Riboside Exercise Performance Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.

topic	claim	evidence level	citation	source
Nicotinamide Riboside Exercise Performance Randomized Trial	This review summarizes current evidence on nutritional compounds that target aging-related pathways, focusing on interventions that influence mitochondrial health, cognitive performance, immune function, metabolic regulation, and maintenance of muscle mass in older adults.	4	Kurtz JA (2026)	Targeted Supplementation and Nutritional Strategies for Healthy Aging: A Review of Physiological and Molecular Benefits.
Nicotinamide Riboside Exercise Performance Randomized Trial	Recent findings Evidence indicates that several targeted nutrients, including protein, probiotics, antioxidants, and emerging mitochondrial-support compounds, may contribute to healthy aging.	4	Kurtz JA (2026)	Targeted Supplementation and Nutritional Strategies for Healthy Aging: A Review of Physiological and Molecular Benefits.
Nicotinamide Riboside Exercise Performance Randomized Trial	A personalized, evidence-informed supplementation strategy integrated with exercise and balanced nutrition may help optimize physiological function in aging adults.	4	Kurtz JA (2026)	Targeted Supplementation and Nutritional Strategies for Healthy Aging: A Review of Physiological and Molecular Benefits.
Nicotinamide Riboside Exercise Performance Randomized Trial	Purpose of review Aging is marked by progressive physiological decline driven by chronic inflammation, mitochondrial dysfunction, and impaired metabolic and musculoskeletal resilience.	4	Kurtz JA (2026)	Targeted Supplementation and Nutritional Strategies for Healthy Aging: A Review of Physiological and Molecular Benefits.
Nicotinamide Riboside Exercise Performance Randomized Trial	Sarcopenia is a progressive and multifactorial muscle disorder associated with diminished strength, reduced functional capacity, and increased risk of adverse health outcomes including frailty, falls, and mortality.	4	Chin HS (2026)	Molecular Mechanisms and Nutritional Modulation in Sarcopenia: A Narrative Review.
Nicotinamide Riboside Exercise Performance Randomized Trial	This review examines emerging evidence linking anabolic resistance, mitochondrial dysfunction, neuromuscular instability, and chronic inflammation to impaired regeneration and disrupted proteostasis.	4	Chin HS (2026)	Molecular Mechanisms and Nutritional Modulation in Sarcopenia: A Narrative Review.
Nicotinamide Riboside Exercise Performance Randomized Trial	Although exercise remains the cornerstone therapy, its benefits are often constrained in patients with multimorbidity or reduced mobility.	4	Chin HS (2026)	Molecular Mechanisms and Nutritional Modulation in Sarcopenia: A Narrative Review.
Nicotinamide Riboside Exercise Performance Randomized Trial	Despite its clinical burden, the molecular pathogenesis of sarcopenia remains poorly understood, which hinders the development of precise therapeutic strategies.	4	Chin HS (2026)	Molecular Mechanisms and Nutritional Modulation in Sarcopenia: A Narrative Review.